298
Participants
Start Date
April 30, 1999
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
Daclizumab
daclizumab 1 mg/kg/dose every 14 days for 5 doses
Cornell University, Ithaca
Washington Hospital, Washington D.C.
University of Maryland, College Park
Medical College of Virginia, Richmond
Duke University, Durham
Carolina Medical Center, Charlotte
Medical University of South Carolina, Charleston
Emory University, Atlanta
University of Miami, Miami
University of Tennessee, Memphis
Ohio State University, Columbus
University of Iowa, Iowa City
Medical College of Wisconsin, Milwaukee
University of Wisconsin, Madison
University of Minnesota, Minneapolis
Northwestern University, Chicago
University of Chicago, Chicago
Baylor University, Waco
University of Texas - Houston, Houston
University of California - Los Angeles, Los Angeles
University of California - Davis, Davis
Oregon Health Science University, Portland
University of Washington, Seattle
Toronto Hospital, Toronto
Roche Pharma AG
INDUSTRY
University of Tennessee
OTHER
University of Cincinnati
OTHER